Intraosseous vs Intravenous Access for Cardiac Arrest Treatment
Clinical Evaluation of Intraosseous and Intravenous Access for Cardiac Arrest Treatment in Emergency Ambulances In Singapore
2 other identifiers
interventional
1,103
1 country
1
Brief Summary
In patients with out-of-hospital cardiac arrest in Singapore, investigators aim to assess the benefit of introducing a resuscitation protocol including the use of intravenous (IV) access and/or intraosseous (IO) vascular access in the pre-hospital setting. The assumption is that low vascular access rates could be due to difficulty of setting IV cannulas in the field due to certain factors like poor lighting or space constraints. Thus, by introducing a protocol including IO access for difficult IV cases, success rates for vascular access will be higher and this might lead to higher survival rates. This will be a study comparing 'IV+IO' and 'IV alone' protocols in patients with cardiac arrest managed by Singapore Civil Defence Force (SCDF) emergency ambulance service. The trial will recruit 400 patients over 1 year. Each of the 30 SCDF ambulances will provide both 'IV+IO' and 'IV alone' treatments in 2 consecutive phases of 6-months in order to allow for all ambulance crew a chance to be trained on usage of IO. Currently, IO insertion is the accepted standard of care in Singapore General Hospital, Department of Emergency Medicine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jun 2014
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2014
CompletedFirst Posted
Study publicly available on registry
March 17, 2014
CompletedStudy Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedOctober 28, 2019
October 1, 2019
2.6 years
March 11, 2014
October 23, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Any Return of Spontaneous Circulation Rate (ROSC)
Any ROSC including transient or intermittent during pre- or in-hospital
At scene to hospital (about 2 hours)
Secondary Outcomes (4)
Insertion success rate
90 secs
Number of patients administered 1st dose
90 secs
Survival outcome
up to 30 days
Time taken for 1st dose of adrenaline given
90 secs
Study Arms (2)
Intravenous and Intraosseous
ACTIVE COMPARATOR'IV + IO' Intravenous fluids or medications needed and a peripheral IV given 2 attempts or 90 seconds. If IV is unsuccessful, IO will attempt at the Primary site (proximal tibia). If IO is unsuccessful at scene, 2nd attempt can be done in the ambulance. Adrenaline will be delivered as according to protocol.
Intravenous
EXPERIMENTALIntravenous fluids or medications needed and a peripheral IV given 2 attempts or 90 seconds. If 1st IV is unsuccessful at scene, 2nd IV attempt can be done in the ambulance. Adrenaline will be delivered according to protocol.
Interventions
Eligibility Criteria
You may qualify if:
- Cardiac arrest (medical or traumatic)
- Intravenous fluids or medications needed
You may not qualify if:
- Adult needle (weight ≥ 40 kg)
- Paediatric needle (weight 3 - 39 kg)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Singapore General Hospitallead
- Singapore Civil Defence Forcecollaborator
Study Sites (1)
Singapore Civil Defence Force
Singapore, Singapore
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kenneth Boon Kiat Tan, MBBS
Singapore General Hospital
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 11, 2014
First Posted
March 17, 2014
Study Start
June 1, 2014
Primary Completion
January 1, 2017
Study Completion
June 1, 2017
Last Updated
October 28, 2019
Record last verified: 2019-10